HPS Pharmacies wish to give notice that Pfizer Australia are experiencing an interruption to the supply of DBL™ vinblastine vials as follows:
This supply interruption is due to a manufacturing delay. Normal supplies of DBL™ vinblastine 10mg/10ml vials are expected to resume in early October 2017. Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 629 921.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.